PTI.The drug firm over the past few weeks has ramped up supply of multiple medicines including Remdesivir to meet the surge in demand, he added."We are also working on the launch of newer treatment options, which we will bring to the market in the next few months.
We have also ensured that supplies of our existing medicines continue uninterrupted and we continue to meet the market demand for all our markets," Prasad noted.Commenting on business opportunities arising from the Sputnik V, Dr Reddy's CEO Erez Israeli said: "We have the rights for the first 250 million of doses for India which translates to 125 million patients.